COLISTIMETHATE FOR INJECTION, USP
Google image searchProduct monograph
Active ingredient
colistin (colistimethate sodium), 150 MG/VIAL
DIN: 02403544
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 16-DEC-2024
ATC:
- J01 — ANTIBACTERIALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J01X — OTHER ANTIBACTERIALS (ATC, ATC/DDD)
- J01XB — Polymyxins (ATC, ATC/DDD)
- J01XB01 — COLISTIN (ATC/DDD)
Pharmaceutical standard: USP
